Autosomal Recessive Polycystic Kidney Disease
📧 Sign up to get email alerts when something new happens for Autosomal Recessive Polycystic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) [Phase 3]
A Phase 3 study evaluating tolvaptan to delay dialysis in infants and young children with autosomal recessive polycystic kidney disease has …